Our research provides a valuable indication that ASPP1 could be a prognostic indicator of CRC and patients with low ASPP1 levels could be more suitable for therapy with NF-κB inhibitors55,56. The gene discussed is PPP1R13B; the disease is colorectal carcinoma.